Correction to: γ -Fe 2 O 3 Loading Mitoxantrone and Glucose Oxidase for pH-Responsive Chemo/Chemodynamic/Photothermal Synergistic Cancer Therapy (Advanced Healthcare Materials, (2022), 11, 11, (2102632), 10.1002/adhm.202102632)

Adv. Healthcare Mater. 2022, 11, 2102632 https://doi.org/10.1002/adhm.202102632 In the original published version of this article, in Figure 4d, the JC-1 picture of G1 (row 2, column 1) is incorrect, and the correct version is shown here. 4 Figure (Figure presented.) d) The changes of mitochondrial membrane potential were observed by JC-1 staining (scale bar: 10 μm). (G1: control group, G2: GOx@γ-Fe₂O₃ NPs group, G3: MTO-γ-Fe₂O₃ NPs group, G4: MTO-GOx@γ-Fe₂O₃ NPs group, and G5: MTO-GOx@γ-Fe₂O₃ NPs under laser irradiation group). In Figure 6d, the lung's H&E staining picture of the G4 was misused in G5 (row 5, column 4), and the correct version is shown below. 6 Figure (Figure presented.) d) H&E staining of major organs (heart, liver, spleen, lung, and kidney) and tumors collected from different groups. (scale bar: 30 μm). (G1: control, G2: GOx@-Fe₂O₃ NPs, G3: MTO-Fe₂O₃ NPs, G4: MTO-GOx-Fe₂O₃ NPs, and G5: MTO-GOx@-Fe₂O₃ NPs under laser irradiation). These corrections do not alter any conclusion of this paper. The authors apologize for any inconvenience caused.